Cornercap Investment Counsel Inc Annexon, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 46,698 shares of ANNX stock, worth $224,150. This represents 0.05% of its overall portfolio holdings.
Number of Shares
46,698
Previous 46,698
-0.0%
Holding current value
$224,150
Previous $212,000
57.55%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ANNX
# of Institutions
138Shares Held
87.3MCall Options Held
2.54MPut Options Held
556K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.7MShares$41.8 Million9.43% of portfolio
-
Satter Management Co., L.P.7.41MShares$35.5 Million59.29% of portfolio
-
Bvf Inc San Francisco, CA7MShares$33.6 Million1.5% of portfolio
-
Redmile Group, LLC San Francisco, CA5.5MShares$26.4 Million1.56% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.16MShares$24.8 Million0.09% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $229M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...